528 material Form 8-K filings that 462 companies we cover made with the SEC in January 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cleveland-Cliffs said on January 3, 2025 that its board appointed Jane M. Cronin as a director, effective immediately, and as a member of the Audit Committee. The board determined she is independent under New York Stock Exchange standards. The filing is a routine board addition and does not describe any change to company financials or operations.
Jane M. Cronin appointed to the Board effective January 3, 2025; board deems her independent
Cronin joins the Audit Committee
She receives nonemployee director pay, including a prorated restricted share award and quarterly retainer fees under the 2021 Nonemployee Directors' Compensation Plan
Company expects to sign a standard director and officer indemnification agreement with her
Blackstone Mortgage Trust elected Marcin Urbaszek as Deputy Chief Financial Officer and Principal Accounting Officer, effective January 2, 2025. Director Thomas E. Dobrowski gave notice of his resignation from the board effective January 15, 2025, and the board reduced its size from nine members to eight.
Marcin Urbaszek, 48, was elected Deputy CFO and Principal Accounting Officer on January 2, 2025; he previously served as CFO of Granite Point Mortgage Trust (NYSE: GPMT)
Thomas E. Dobrowski resigned from the board effective January 15, 2025, after 26 years of service to the company and its predecessor business
The filing states Dobrowski's resignation was not the result of any disagreement with the company on operations, policies or practices
Board size decreased from nine members to eight, effective upon Dobrowski's resignation
American Homes 4 Rent said Bryan Smith became chief executive officer effective January 1, 2025, succeeding David P. Singelyn, who retired on December 31, 2024. The Board also expanded from twelve to thirteen trustees and appointed Smith as a trustee, without compensation for that role.
Bryan Smith succeeds David P. Singelyn as CEO, effective January 1, 2025
Singelyn retired on December 31, 2024
Board size increased from twelve to thirteen trustees; Smith appointed trustee effective January 1, 2025
Smith will not receive compensation for his trustee service; no related-person transactions required under Item 404(a)
CNO Financial Group named Joel Koehneman, a former PricewaterhouseCoopers audit partner and most recently a finance director at CDW Corporation, as chief accounting officer effective January 21, 2025. He succeeds Michellen Wildin, who was told of her replacement on January 2, 2025, and who will stay with the company through April 1, 2025 to support the transition, with the company saying her departure does not involve any disagreement on financial statements or internal controls.
Joel Koehneman, 39, becomes chief accounting officer effective January 21, 2025, and reports to CFO Paul McDonough
Compensation includes a $300,000 annual salary, a 50% target bonus, and a $100,000 one-time sign-on bonus
Michellen Wildin remains chief accounting officer through January 20, 2025 and is expected to stay through April 1, 2025
The company states Wildin's separation is not due to any disagreement on financial statements, internal control, operations, policies or practices
Simpson Manufacturing Co., Inc. appointed Angela Drake as an independent, non-employee director effective January 1, 2025, and named her to the Audit and Finance and Compensation and Leadership Development committees. The filing says she will receive a pro-rated annual restricted stock unit award valued at $42,789 on the grant date of January 1, 2025, and the company describes her financial leadership background, including her role as Chief Financial Officer of The Toro Company since March 2023.
Angela Drake appointed independent non-employee director, effective January 1, 2025
Named to Audit and Finance and Compensation and Leadership Development committees
Pro-rated annual RSU award valued at $42,789 on grant date January 1, 2025
Board determined she meets NYSE and Rule 10A-3 independence requirements
Haemonetics said Executive Vice President of Global Manufacturing and Supply Chain Josep Llorens will retire effective July 11, 2025. He will stay in his role while the company searches for a successor and will help the CEO with the transition until he leaves. The change involves a named executive officer in charge of manufacturing and supply chain, but the filing gives no financial impact.
Josep Llorens, Executive Vice President, Global Manufacturing and Supply Chain, will retire effective July 11, 2025
Llorens will remain in his current role while the company searches for a successor
Llorens will assist CEO Christopher A. Simon with the transition until his retirement
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.